TABLE 1.
Description of study population (n=4561)
| Characteristic | n (%)* |
|---|---|
| Sex | |
| Female | 2792 (61.2) |
| Male | 1769 (38.8) |
| Age groups | |
| <40 years | 97 (2.1) |
| 40 to 59 years | 859 (18.8) |
| 60 to 79 years | 2841 (62.3) |
| ≥80 years | 764 (16.8) |
| Age, years (mean ± SD) | 68.6±12.4 |
| Chronic diseases score (mean ± SD) | 2.9±2.7 |
| Antihypertensive agents† | |
| Calcium channel blockers | 1219 (26.7) |
| Diuretics | 1741 (38.2) |
| Angiotensin-I converting enzyme inhibitors | 1731 (38.0) |
| Angiotensin-II receptor blockers | 962 (21.1) |
| Beta-blockers | 1143 (25.1) |
*
Data are presented as n (%) unless otherwise specified;
†Total is more than 100% because some patients used more that one agent